Paul Batty/LinkedIn
Sep 18, 2025, 09:15
Paul Batty: The Hepatic Odyssey of AAV Gene Therapy in Hemophilia
Paul Batty, Associate Professor at University College London and Honorary Consultant in Haemostasis and Thrombosis at the Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, shared a post on X:
”Our educational review summarising the hepatic lifecycle of AAV gene therapy and how this is linked to treatment outcomes has been published in the Journal of Thrombosis and Haemostasis.”
Title: The Hepatic Odyssey of AAV: From Gene Delivery to Long-Term Outcomes
Authors: Giulia Simini, Paul Batty
Read the full article here.
Stay updated with Hemostasis Today.
-
Oct 2, 2026, 18:34Kamini Khillan: Massive Transfusion Protocol for PPH Management
-
Oct 2, 2026, 18:24Garima Sharma։ GLP-1 Receptor Agonists Across the Reproductive Life Course
-
Oct 2, 2026, 18:13Priya Sriskandarajah: Roginolisib Plus JAK Inhibitors in Myelofibrosis
-
Oct 2, 2026, 17:40Chokri Ben Lamine: A Two-Day Journey Through Modern Hematology at KFSHRC
-
Oct 2, 2026, 17:27Reza Shojaei: The Invisible Crisis, Part 1- Donor Deferral in Whole Blood
-
Oct 2, 2026, 16:02Advancing Antithrombotic Stewardship to Optimise Care – American Heart Association
-
Oct 2, 2026, 15:37Pall T. Onundarson: Monitoring Warfarin Beyond Factor VII
-
Oct 2, 2026, 15:26Nicola Carter: World Thrombosis Day Highlights Gender Specific Risks and Prevention
-
Oct 2, 2026, 14:56Wolfgang Miesbach: Direct Comparison Reveals Distinct Mechanisms Among FVIIIa Mimetics